secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K
Filed at:   2026-01-29T23:59:59+00:00
Accession:  0001193125-26-028186
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Definium Therapeutics appoints Roger Adsett to board, expanding to 7 directors
------------------------------------------------------------------------------

- Board increased from 6 to 7 directors; Adsett appointed effective Jan 29, 2026.
- Adsett receives $40,000 annual cash retainer paid quarterly in arrears.
- Granted option for 50,000 common shares; vests 1/3 on first anniversary, then monthly.
- Not assigned to any board committees initially.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000119312526028186/0001193125-26-028186-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000119312526028186/dftx-20260128.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-028186

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer